Drawing for TEVOSOL

USPTO serial 88652050

TEVOSOL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
GAGLIARDI, JEANINE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TEVOSOL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ge (Linda) Lei

Ge (Linda) Lei GETECH LAW LLC203 N LASALLE ST, SUITE 2100CHICAGO, IL 60601UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005medical preparations for use in organ transplantation; medical preparations for preserving human organs awaiting transplantation; chemical preparations and substances for perfusion and reperfusion of explanted organs, and for transport, storage, managing, assessment and treatment of tissues and organs for humans for medical purposes; cardioplegic solutions in the nature of medical preparations for temporary cessation of cardiac activity; cardioplegic solutions used in cardiac surgery in the nature of medical preparations for temporary cessation of cardiac activity; medical preparations for organ perfusion; medical preparations for resuscitation, perfusion, preservation, assessment, evaluation, transportation, and storage of explanted organs following explant and prior to transplant into a recipient; chemical preparations for organ perfusion, reperfusion, preservation, maintenance, evaluation and resuscitation in humans for medical purposes; medical preparations for resuscitation, preservation, and assessment of explanted organs, namely, hearts, lungs, livers and kidneys; blood substitutes for humans; blood plasma substitutes for human use; blood substitutes and blood plasma substitutes for medical purposes, namely, for use in the resuscitation, preservation, and assessment of explanted organs in humans; medical preparations, namely, perfusion solutions for perfusion of ex vivo organs, tissues and cells; sterile and non-toxic medical preparations for in-vitro perfusion, preservation, assessment, transportation, and storage of explanted organs following explant and prior to transplant into a recipient; medical preparations for organ preservation; medical preparations for use in heart transplantation; medical preparations for use in lung transplantation; medical preparations for use in kidney transplantation; medical preparations for use in liver transplantationACTIVE—
010medical apparatus and instruments for organ perfusion and reperfusion; medical devices for preserving human organs awaiting transplantation; portable medical devices for preserving human organs awaiting transplantation; medical devices for assessing viability of human organs awaiting transplantation; portable medical devices for assessing viability of human organs awaiting transplantation; medical devices for resuscitating human organs for organ transplantation; portable medical devices for resuscitating human organs for organ transplantation; medical apparatus and instruments for use in organ transplant; medical apparatus and instruments for resuscitation, preservation, and assessment of explanted organs; medical apparatus and instruments for resuscitation, preservation, and assessment of explanted organs, namely, hearts, lungs, livers and kidneys; heart monitors; medical ventilators; medical respirators for artificial respiration; respirators in the nature of apparatus for artificial respiration; respirators for artificial respiration; resuscitators; magnetic connectors for use in artificial heart, lung, liver, and kidney support and use with medical respirators for medical purposes; pumps for medical purposes, namely, blood pump system for use in artificial heart, lung, liver, and kidney support; pumps for medical purposes, namely, pumps for controllably circulating fluids and solutions through explanted organs, and pumps for use in perfusion circuits; perfusion pumps in the nature of a blood pump for use in explanted organs in the nature of hearts, lungs, livers, and kidneys; medical apparatus in the nature of valves for pumps used in the field of organ perfusion, reperfusion, preservation and transplantation; surgical and medical apparatus and instruments for assessment and transplant of organs; surgical and medical apparatus and instruments for perfusion and reperfusion of organs with fluid for the purpose of preservation, maintenance, assessment and resuscitation; portable organ preservation and transportation systems comprising an organ chamber in the nature of a medical device for storage, preservation, and perfusion of organs, perfusion circuit in the nature of medical apparatus for perfusion, and medical apparatus for organ temperature control, blood oxygenation, and blood flow; organ chambers in the nature of a medical device for storage, preservation, and perfusion of organs and perfusion circuits in the nature of medical apparatus for perfusion for use in portable organ preservation systemsACTIVE—
037Installation, maintenance and repair of medical and surgical devices, apparatus and instruments not in the nature of medical services; Installation, maintenance and repair of medical and surgical devices, apparatus and instruments in the field of preservation, maintenance, assessment and resuscitation of organs not in the nature of medical servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 23, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 23, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 14, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 12, 2021EX3GSOU EXTENSION 3 GRANTED—
Oct 12, 2021EXT3SOU EXTENSION 3 FILED—
Oct 12, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 31, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 29, 2021EX2GSOU EXTENSION 2 GRANTED—
Mar 29, 2021EXT2SOU EXTENSION 2 FILED—
Mar 29, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 3, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 1, 2020EX1GSOU EXTENSION 1 GRANTED—
Oct 1, 2020EXT1SOU EXTENSION 1 FILED—
Oct 1, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 21, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 25, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 25, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 5, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 23, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 23, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jan 23, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 23, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 23, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 16, 2020DOCKASSIGNED TO EXAMINER—
Oct 17, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 15, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance